Keywords: ترجیحی; Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
مقالات ISI ترجیحی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترجیحی; AEs; adverse events; ITT; intention-to-treat; MedDRA; Medical Dictionary for Regulatory Activities; MITT; modified intention-to-treat; MPP; modified per-protocol; PP; per-protocol; PT; preferred term; SD; standard deviation; SOC; system organ class; Otomy
Keywords: ترجیحی; Phentolamine mesylate effectiveness; safety; noninterventional study; Germany; ADRs; Adverse drug reactions; AEs; Adverse events; MedDRA SOC; Medical Dictionary for Regulatory Activities System Organ Class; NA; Not applicable; ORANIS; OraVerse Non-Interv
Adverse Events following Haemophilus influenzae Type b Vaccines in the Vaccine Adverse Event Reporting System, 1990-2013
Keywords: ترجیحی; AE; Adverse event; EB; Empirical Bayesian; Hib; Haemophilus influenzae type b; MedDRA; Medical Dictionary for Regulatory Activities; PT; Preferred term; SIDS; Sudden infant death syndrome; VAERS; Vaccine Adverse Event Reporting System;
A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic
Keywords: ترجیحی; AE; adverse event; AESI; adverse event of special interest; CHMP; Committee for Medicinal Products for Human Use; EMA; European Medicines Agency; HLT; High Level Term; PT; Preferred Term; SAE; serious adverse event; SOC; System Organ Class; WHO; World Hea
Analysis of behavior-related adverse experiences in clinical trials of montelukast
Keywords: ترجیحی; Montelukast; placebo; clinical trial; behavior; psychiatric; adverse experiences; asthma; allergic rhinitis; AE; Adverse experience; Akath-PT; Akathisia-related preferred term; BRAE; Behavior-related adverse experience; CNS; Central nervous system; CysLT1
Experience using MedDRA for global events coding in HIV clinical trials
Keywords: ترجیحی; MedDRA; Adverse events; Lowest level term; Preferred term; Clinical trials